Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro
Prevention of Anthracycline- induced Cardiotoxicity
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology
Frontiers | Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies
Chemotherapy And Cardiotoxicity
Survivorship: Managing Cardiac Toxicities
Anthracycline-Induced Cardiotoxicity in Adults
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer | PLOS ONE
Anthracycline-induced cardiotoxicity: mechanisms of action, incidence, risk factors, prevention, and treatment | SpringerLink
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer | JACC: CardioOncology
Meta-Analysis of Carvedilol for the Prevention of Anthracycline-Induced Cardiotoxicity - American Journal of Cardiology
Conventional echocardiographic parameters and cumulative dose of... | Download Table
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk - Annals of Oncology
Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer | Journal of Clinical Oncology
Learning from an anthracycline error
crt-40-121-i001.jpg
Predicting and Preventing Anthracycline-Related Cardiotoxicity | American Society of Clinical Oncology Educational Book
![Conversion factor for the anthracyclines [8] | Download Table](https://www.researchgate.net/profile/Erland-Erdmann/publication/5658909/figure/tbl2/AS:667044148166672@1536047126862/Conversion-factor-for-the-anthracyclines-8.png "Conversion factor for the anthracyclines [8] | Download Table")
Conversion factor for the anthracyclines [8] | Download Table
Derivation of anthracycline equivalence to doxorubicin in relation to late cardiotoxicity: epirubicin, idarubicin and mitoxantro
Frontiers | Novel Therapeutics for Anthracycline Induced Cardiotoxicity
Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies - Annals of Oncology
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). | Semantic Scholar
Anthracycline-Induced Cardiotoxicity in Adult Hematologic Malignancies - ScienceDirect
